找不到产品？留下需求帮您找
一键询价-
HLE-B3 人正常眼睛晶状体上皮细胞 QCH781
一周
5000￥
-
NOMO-1 人白血病细胞 QCH782
一周
3500￥
-
BPH-1 人前列腺增生细胞 QCH783
一周
4000￥
-
OCIM2 人急性粒细胞白血病 QCH784
一周
4000￥
-
GM12878 人B淋巴细胞 XY-H785
一周
4000￥
-
A-427 人肺癌细胞 QCH786
一周
2500￥
-
SNU475 人肝癌细胞 QCH787
一周
4000￥
-
NCI-H889 人小细胞肺癌细胞 QCH788
一周
3500￥
-
HCC4006 人肺腺癌细胞QCH789
一周
3500￥
-
TMK-1 人胃癌细胞 QCH790
钦诚生物 | 一周
2000￥
获取电话| 公告提醒：爱必信所有产品和服务仅用于科学研究，不用于临床应用及其他用途提供产品和服务（也不为任何个人提供产品和服务）!
抑制剂描述： 产品名称：PE859 产品别名：见爱必信官网 英文别名：PE859 靶点：Amyloid-β CAS：1402727-29-0 纯度：98% 外观：见爱必信官网 保存方法：store at -20℃ for one year（Powder） 描述： PE859 is a potent inhibitor of both tau and Aβ aggregation with IC50 values of 0.66 and 1.2 μM, respectively. 溶解性：DMSO : 50 mg/mL (111.48 mM; Need ultrasonic) 体外研究： PE859 inhibits the heparin-induced aggregation of both 3RMBD and full length tau in a concentration-dependent manner. In each assay, the IC50 values calculated at the last measurement periods are 0.81 μM, and 2.23 μM, respectively. PE859 inhibits tau aggregation through formation of beta-sheet structure. 体内研究：PE859 inhibits the heparin-induced aggregation of both 3RMBD and full length tau in a concentration-dependent manner. In each assay, the IC50 values calculated at the last measurement periods are 0.81 μM, and 2.23 μM, respectively. PE859 inhibits tau aggregation through formation of beta-sheet structure.
产品信息订购：
|